Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4

Potential Contribution to High First-Pass Metabolism

Michael E. Fitzsimmons and Jerry M. Collins
Drug Metabolism and Disposition February 1997, 25 (2) 256-266;
Michael E. Fitzsimmons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry M. Collins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 25 no. 2 256-266
PubMed 
9029057

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 12, 1996
  • Accepted November 19, 1996
  • Published online February 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Michael E. Fitzsimmons and
  2. Jerry M. Collins
  1. Laboratory of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to March 2023

    AbstractFullPdf
    Aug 201741712
    Sep 20170158
    Oct 201714016
    Nov 20175313
    Dec 20170183
    Jan 20182293
    Feb 20182135
    Mar 20183102
    Apr 20182199
    May 20187189
    Jun 20181268
    Jul 201872012
    Aug 201841310
    Sep 201822514
    Oct 20184861
    Nov 20181824
    Dec 201851113
    Jan 20196765
    Feb 20195000
    Mar 20191630
    Apr 2019610
    May 2019622
    Jun 2019702
    Jul 20191022
    Aug 20191530
    Oct 20191901
    Nov 20194310
    Dec 20192981
    Jan 20201122
    Feb 20202224
    Mar 2020782
    May 2020600
    Jun 20201632
    Jul 20201620
    Aug 2020200
    Sep 20201010
    Oct 2020511
    Nov 2020911
    Dec 20202181
    Jan 202112323
    Feb 202110271
    Mar 20214071
    Apr 20211210
    May 20212050
    Jun 202117222
    Jul 2021630
    Aug 20219172
    Sep 20211170
    Oct 2021730
    Nov 20212820
    Dec 202126101
    Jan 2022342
    Feb 20221531
    Mar 20224231
    Apr 202261111
    May 20221311
    Jun 20222510
    Jul 20222031
    Aug 20222632
    Sep 20221520
    Oct 202214152
    Nov 20222021
    Dec 2022410
    Jan 20235430
    Feb 20231820
    Mar 2023920

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition
    Vol. 25, Issue 2
    1 Feb 1997
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4

    Michael E. Fitzsimmons and Jerry M. Collins
    Drug Metabolism and Disposition February 1, 1997, 25 (2) 256-266;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4

    Michael E. Fitzsimmons and Jerry M. Collins
    Drug Metabolism and Disposition February 1, 1997, 25 (2) 256-266;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Metabolic enzymes in nintedanib metabolism
    • Mechanism of AO Inactivation by Hydralazine
    • Warfarin PBPK modeling with target binding
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics